Merz Pharma GmbH & Co. KGaA is a privately-held pharmaceutical company based in Frankfurt, Germany with affiliates across Europe, as well as the US, Canada, Mexico, Brazil and Asia Pacific and regional headquarters in Singapore and North Carolina, USA. The company is active in research, development and distribution of innovative products in the areas of aesthetic medicine and neurologically induced movement disorders. In German-speaking countries, our consumer products segment, Merz Consumer Care, is a leading provider of innovative health, wellness and beauty products with its well-known tetesept® and Merz Spezial® brands. Today, Merz’s global business is focused on the areas of medical aesthetics and neurotoxin therapy, supported by a number of successful regional brands in both the prescription medicine and consumer health and beauty sectors. Key brands in the portfolio include Belotero®, Radiesse, Cellfina, Ultherapy, Botulinum Toxin and Neocutis.
History
Merz has been a successful specialty healthcare company for more than 110 years. The company was founded in 1908 in Frankfurt, Germany by a 24-year old chemist named Friedrich Merz, and is still owned by the fourth-generation of the Merz family. 1908 – Company founded 1911 – Introduction of first topical contraceptive Patentex 1953 – Launch of anti-wrinkle moisturizing creamPlacentubex® 1964 – Development of Merz Spezial Dragees from 18 different active ingredients 1965 – Introduction of tetesept bath medicine 1968 – Launch of Placentubex® Foaming Mask 2002 – Introduction of Memantine for the treatment of Alzheimer’s disease 2005 – Merz launches a next generation of Botulinum Toxin 2010 – Acquisition of Bioform and its flagship productRADIESSE® 2013 – Acquisition of Anteis and its range of dermal fillers, Belotero® 2013 – Acquisition of Swiss skincare company Neocutis 2014 – Acquisition of the Ulthera® System, the first ultrasound platform device with FDA clearance 2015 – Launch of Radiesse® Lidocaine in the US market 2015 – Establishment of Asia Pacific regional Headquarters in Singapore 2016 – Acquisition of ON Light Sciences with its flagship product DeScribe® 2016 – Launch of the Cellfina® System in the US, minimally-invasive cellulite treatment 2018 – Launch of Belotero® Lips 2019 - Launch of Belotero® Revive
